Abstract
Intravenous administration of glucagon to 12 dogs and nine people produced significant depression of plasma total lipid and cholesterol at 1 2 to 2 hours. There was no significant change of whole blood total lipid. Incubation at 37°C of aliquots of blood completely or partially restored plasma lipid and cholesterol levels previously depressed by glucagon. In vitro dose-response curves showed concentrations of glucagon comparable to those following I.V. administration of glucagon (1 mg.) caused similar depression of plasma total lipid. In vitro study of the blood of seven people showed glucagon caused significant depression of plasma total lipid and cholesterol from 1 2 through 3 hours while incubation completely or partially restored depressed levels. These findings indicated glucagon lowered plasma lipid and cholesterol by transfer of lipid to the blood cell(s). Study of six people to determine the cell(s) involved showed glucagon caused significant depression of plasma lipid at 1 and 2 hours in platelet-rich plasma only while there was no change in platelet-poor blood, cell-free plasma, and normal saline controls. It was concluded the hypolipemic action of glucagon is due to transfer of plasma lipid to blood platelets which release the lipid back to plasma when the action of glucagon ceases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.